A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva

Gingival Recession Clinical Trial

Official title:

A Pilot Clinical Trial to Assess the Safety and Efficacy of Gintuit (TM) (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen) in Establishing a Functional Zone of Attached Gingiva

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01547962
• Other study ID #: 05-PER-001
• Status: Completed
• Phase: N/A
• First received: February 28, 2012
• Last updated: April 6, 2012
• Start date: September 2005
• Est. completion date: May 2006

Study information

• Verified date: April 2012
• Source: Organogenesis
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of Gintuit compared to a free autogenous graft using donor tissue harvested from the subject's palate in the treatment of subjects who have an insufficient zone of attached gingiva associated with at least two non adjacent teeth. The trial is designed to demonstrate non-inferiority between treatment and control in the change in amount of attached gingiva over the 6 month observation period.

Gintuit will be placed as a graft in one of the deficient zones, and a free autogenous graft will be placed in the other. The grafts will be evaluated clinically to determine the change in the amount of attached gingiva and on at least three subjects, a small biopsy will be taken to allow histologic evaluation and comparison of both grafts.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: May 2006
• Est. primary completion date: May 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. Subject is 18 years of age or older at the time of enrollment, and not older than seventy years.

2. Subject has at least two non-adjacent teeth with an insufficient zone of attached gingiva which requires soft tissue grafting. The two selected teeth must be located in contralateral quadrants. (In case of adjacent teeth requiring grafting, only one tooth at each site will act as test or control tooth, but both teeth will get the same treatment).

3. Root coverage is not desired or indicated at the time of grafting.

4. Females of childbearing potential must have a documented negative urine or serum pregnancy test.

5. Subjects must have read, understood and signed an institutional review board (IRB) approved Informed Consent Form.

6. Subjects must be able and willing to follow study procedures and instructions.

Exclusion Criteria:

1. Teeth that have an insufficient zone of attached gingiva that would be best treated using soft tissue grafts, which would attempt to cover the denuded root surface.

2. Subjects with any systemic conditions (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) which could compromise wound healing and preclude periodontal surgery.

3. Subjects who are currently receiving or have received within one week prior to study entry, systemic corticosteroids (including inhaled), immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery.

4. Subjects with the presence of acute infectious lesions in the areas intended for surgery.

5. Subjects who smoke.

6. Teeth requiring treatment are molars.

7. Teeth with axial mobility.

8. Known hypersensitivity to bovine collagen.

9. Subjects enrolled in medical, dental, or any investigational device study for any disease within the past four weeks.

10. Subjects who have received an investigational drug or biological treatment within the three months prior to study enrollment (medical or dental).

11. Subjects previously treated with Gintuit, Dermagraft or any other skin graft at the target site(s).

12. Subjects who, in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Gingival Recession

Intervention

Device:
• Gintuit
Gintuit is prepared in a "S" fold and trimmed to fit the prepared wound bed, with a standardized width of 5 mm and sutured in place with a 5/0 gut suture.

Other:
• autologous Free Gingival Graft (FGG)
Autologous FGG harvested from the subject's palate, the width of the FGG will be 5 mm and sutured in place with a 5/0 gut suture.

Locations

Country	Name	City	State
United States	PerioHealth	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Organogenesis

Country where clinical trial is conducted

United States, 

References & Publications (1)

McGuire MK, Scheyer ET, Nunn ME, Lavin PT. A pilot study to evaluate a tissue-engineered bilayered cell therapy as an alternative to tissue from the palate. J Periodontol. 2008 Oct;79(10):1847-56. doi: 10.1902/jop.2008.080017 . — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Amount of attached gingiva	Change in the amount of attached gingiva	6 months	No
Secondary	Inflammation	Change from baseline in inflammation score	week 1, week 4, month 3 and month 6	No
Secondary	Color of grafted tissue	Color match of the grafted tissue to the adjacent tissue	4 weeks, 3 months, 6 months	No
Secondary	Texture of grafted tissue	Texture match of the grafted tissue to the adjacent tissue	4 weeks, 3 months, 6 months	No
Secondary	Oral muscle pull	Resistance to oral muscle pull	6 months	No
Secondary	Probing depth	Change in probing depth from baseline	6 months	No
Secondary	Clinical attachment level (ie, distance from the cemento-enamel junction (CEJ; or another definite chosen landmark) to the base of the sulcus or periodontal pocket)	Change in clinical attachment level (mm) from baseline	6 months	No
Secondary	Overall Subject Preference	VAS scale subject assessment of each treated site with anchors of "disappointed" and "fully satisfied".	6 months	No
Secondary	Recession depth	Change in recession depth	3 months, 6 months	No
Secondary	Keratinized tissue	Width of keratinized tissue	3 months, 6 months	No